| | |
| Clinical data | |
|---|---|
| Trade names | 东卫卓; Dongweizhuo |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| Chemical and physical data | |
| Formula | C51H58N8O7 |
| Molar mass | 895.074 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Netanasvir is an antiviral drug used to treat hepatitis C virus (HCV). [1] In China, netansavir is approved for use in combination with encofosbuvir for the treatment of adult patients with chronic HCV genotypes 1, 2, 3, or 6, who are either treatment-naive or have been previously treated with interferon. [2]